Crews 2001 + Arvinas 2013 PROTAC: bivalent ligand recruits E3-ligase to target -> ubiquitin -> proteasome; ARV-471 estrogen-receptor degrader Phase 3 2024; event-driven pharmacology.
Crews 2001 + Arvinas 2013 PROTAC: bivalent ligand recruits E3-ligase to target -> ubiquitin -> proteasome; ARV-471 estrogen-receptor degrader Phase 3 2024; event-driven pharmacology.